Taysha Gene Therapies, Inc. announced on March 2, 2023, Mr. R.A. Session II notified the board of his resignation from the board and all committees thereof effective immediately. Mr. Session's decision to leave the Board was not the result of any disagreement between the company and Mr. Session on any matter relating to the company's operations, policies or practices.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.14 USD | +0.96% | +24.11% | +77.40% |
May. 14 | Taysha Gene Therapies Q1 Net Loss Narrows, Revenue Declines -- Shares Down After Hours | MT |
May. 14 | Transcript : Taysha Gene Therapies, Inc., Q1 2024 Earnings Call, May 14, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+77.40% | 587M | |
+33.37% | 50.85B | |
+1.55% | 42.82B | |
+49.11% | 42.03B | |
-4.22% | 29.55B | |
+11.57% | 26.11B | |
-21.00% | 19.13B | |
+7.36% | 13.05B | |
+28.30% | 12.16B | |
+23.80% | 12.08B |
- Stock Market
- Equities
- TSHA Stock
- News Taysha Gene Therapies, Inc.
- Taysha Gene Therapies, Inc. Announces Resignation of R.A. Session II from the Board and All Committees